​

Fennec Pharmaceuticals (FENC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FENC Stock Forecast

Fennec Pharmaceuticals (FENC) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $14.00, with a high of $14.00 and a low of $14.00. This represents a 58.73% increase from the last price of $8.82.

$4 $6 $8 $10 $12 $14 High: $14 Avg: $14 Low: $14 Last Closed Price: $8.82

FENC Stock Rating

Fennec Pharmaceuticals stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 7 Strong Sell Sell Hold Buy Strong Buy

FENC Price Target Upside V Benchmarks

TypeNameUpside
StockFennec Pharmaceuticals58.73%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$14.00$14.00
Last Closing Price$8.82$8.82$8.82
Upside/Downside-58.73%58.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2523---5
Sep, 2523---5
Aug, 2523---5
Jul, 2523---5
Jun, 2523---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 15, 2025Chase KnickerbockerCraig-Hallum$14.00$8.5463.93%58.73%
May 15, 2024Chase KnickerbockerCraig-Hallum$17.00$7.34131.61%92.74%
May 15, 2024Raghuram SelvarajuH.C. Wainwright$15.00$7.03113.37%70.07%
Apr 04, 2024Raghuram SelvarajuH.C. Wainwright$18.00$10.7767.13%104.08%
Mar 19, 2024Chase KnickerbockerCraig-Hallum$18.00$11.0163.49%104.08%
Nov 22, 2022Cantor Fitzgerald$12.00$9.1730.86%36.05%
Sep 26, 2022Wedbush$19.00$7.11167.23%115.42%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 15, 2025Craig-HallumBuyBuyhold
May 14, 2025Craig-HallumBuyBuyhold
May 15, 2024Craig-HallumBuyBuyhold
May 15, 2024H.C. WainwrightBuyBuyhold
Apr 04, 2024H.C. WainwrightBuyBuyhold
Nov 22, 2022Cantor FitzgeraldOverweightupgrade
Sep 26, 2022WedbushOutperformOutperformhold
Sep 07, 2022JonesTradingBuyinitialise

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.67$-0.95$-0.60-----
Avg Forecast$0.25$-0.92$-0.51$-0.07$-0.03$1.07$1.66$2.09
High Forecast$0.30$-0.75$-0.49$-0.04$0.07$2.11$2.83$2.74
Low Forecast$0.20$-1.22$-0.53$-0.10$-0.09$0.36$0.55$1.54
Surprise %-368.00%3.26%17.65%-----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$1.53M$21.25M$47.54M----
Avg Forecast$50.00M$893.80K$20.19M$43.03M$48.18M$82.47M$102.98M$115.61M
High Forecast$57.19M$1.12M$25.07M$56.13M$55.53M$83.83M$105.31M$143.54M
Low Forecast$42.61M$768.36K$16.12M$29.93M$40.83M$81.12M$100.66M$92.32M
Surprise %-71.74%5.25%10.48%----

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-17.46M$-24.84M$-16.05M$-70.00K----
Avg Forecast$-47.38M$-24.36M$-13.55M$-1.13M$-1.15M$29.83M$46.35M$55.41M
High Forecast$-37.90M$-19.92M$-13.00M$-1.07M$1.85M$56.07M$75.20M$72.80M
Low Forecast$-56.85M$-32.40M$-14.11M$-2.78M$-2.33M$9.57M$14.62M$40.89M
Surprise %-63.15%1.97%18.39%-93.82%----

FENC Forecast FAQ

Is Fennec Pharmaceuticals stock a buy?

Fennec Pharmaceuticals stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Fennec Pharmaceuticals is a favorable investment for most analysts.

What is Fennec Pharmaceuticals's price target?

Fennec Pharmaceuticals's price target, set by 7 Wall Street analysts, averages $14 over the next 12 months. The price target range spans from $14 at the low end to $14 at the high end, suggesting a potential 58.73% change from the previous closing price of $8.82.

How does Fennec Pharmaceuticals stock forecast compare to its benchmarks?

Fennec Pharmaceuticals's stock forecast shows a 58.73% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Fennec Pharmaceuticals over the past three months?

  • October 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Fennec Pharmaceuticals’s EPS forecast?

Fennec Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.03, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $1.07 in 2026, $1.66 in 2027, and $2.09 in 2028.

What is Fennec Pharmaceuticals’s revenue forecast?

Fennec Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $48.18M, reflecting a 1.35% increase from the reported $47.54M in 2024. The forecast for 2026 is $82.47M, followed by $102.98M for 2027, and $115.61M for 2028.

What is Fennec Pharmaceuticals’s net income forecast?

Fennec Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $-1.147M, representing an 1539.14% increase from the reported $-70K in 2024. Projections indicate $29.83M in 2026, $46.35M in 2027, and $55.41M in 2028.